alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT
      23.1**





**Consent
      of Independent Registered Public Accounting Firm**





The
      Board
      of Directors and Stockholders:


GenVec,
      Inc.:





We
      consent to the incorporation by reference in the Registration Statements on
      Form
      S-3 (No.
      333-140373, No. 333-133366, No. 333-123968, No. 333-101963 and No. 333-76886),
      on Form S-4 (No. 333-105320 **)** and
      on
      Form S-8 (File No. 333-110446, No. 333-55590, No. 333-55586 and No. 333-55584)
      of GenVec, Inc. of our reports dated March 17, 2008, with respect to (1) the
      balance sheets of GenVec, Inc., as of December 31, 2007 and 2006 and the related
      statements of operations, stockholders’ equity and comprehensive loss and cash
      flows for each of the years in the three-year period ended December 31, 2007,
      (2) the effectiveness of internal control over financial reporting as of
      December 31, 2007 which reports appear in the December 31, 2007 annual report
      on
      Form 10-K of GenVec, Inc.





Our
      report refers to the Company’s adoption of Statement of Financial Accounting
      Standards No. 123(R), *Share
      –Based Payment* ,
      on
      January 1, 2006.





*/s/*KPMG
                LLP





McLean,
      Virginia


March
      17,
      2008
This section of the FEDERAL REGISTER

contains editorial corrections of previously

published Presidential, Rule, Proposed Rule,

and Notice documents. These corrections are

prepared by the Office of the Federal

Register. Agency prepared corrections are

issued as signed documents and appear in

the appropriate document categories

elsewhere in the issue.

Corrections Federal Register

17989 

Vol. 72, No. 68 

Tuesday, April, 10, 2007 

COMMODITY FUTURES TRADING 

COMMISSION 

17 CFR Part 30 

Foreign Futures and Options 

Transactions 

Correction 

In rule document 07–1521 beginning 

on page 14413 in the issue of 

Wednesday, March 28, 2007, make the 

following corrections: 

1. On page 14414, in the first column, 

in the last paragraph, in the second to 

last line ‘‘the’’ should read ‘‘and’’. 

2. On the same page, in the second 

column, in the first full paragraph, in 

the seventeenth line, ‘‘that solicit and 

accept customer orders; ’’ should read 

‘‘who accept customer funds;’’. 

[FR Doc. C7–1521 Filed 4–9–07; 8:45 am] 

BILLING CODE 1505–01–D 

cprice-sewell on PROD1PC66 with NOTICES2
[Federal Register Volume 66, Number 12 (Thursday, January 18, 2001)]
[Notices]
[Page 4845]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-1460]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Mental Health, Special 
Emphasis Panel.
    Date: January 29, 20001.
    Time: 1 p.m. to 2 p.m.
    Agency: To review and evaluate grant applications.
    Place: Neuroscience Center, National Institutes of Health, 6001 
Executive Blvd., Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Henry J. Haigler, PhD., Scientific Review 
Administrator, Division of Extramural Activities, National Institute 
of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., 
Rm. 6150, MSC 9608, Bethesda, MD 20892-9608, 301/443-7216.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.242, 
Mental Health Research Grants; 93.281, Scientist Development Award, 
Scientist Development Award for Clinicians, and Research Scientist 
Award; 93.282, Mental Health National Research Service Awards for 
Research Training, National Institutes of Health, HHS)

    Dated: January 9, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-1460 Filed 1-17-01; 8:45 am]
BILLING CODE 4140-01-M
EXHIBIT 31.1
                                 CERTIFICATIONS

          I, Carter M. Fortune, Chief Executive Officer, certify that:

1. I have reviewed this quarterly report on Form 10-QSB/A of Fortune Diversified
Industries, Inc., as amended;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of
Fortune Diversified Industries, Inc. as of, and for, the periods presented in
this quarterly report;

4. I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Securities Exchange Act Rules 13a-14 and 15d-14) for
Fortune Diversified Industries, Inc. and I have done the following:

     a) designed such disclosure controls and procedures to ensure that material
     information relating to Fortune Diversified Industries, Inc. is made known
     to us by others within Fortune Diversified Industries, Inc., particularly
     during the period in which this quarterly report is being prepared;

     b) evaluated the effectiveness of Fortune Diversified Industries, Inc.'s
     disclosure controls and procedures as of a date within 90 days prior to the
     filing date of this quarterly report (the "Evaluation Date"); and

     c) presented in this quarterly report our conclusions about the
     effectiveness of the disclosure controls and procedures based on our
     evaluation as of the Evaluation Date;

5. I have disclosed, based on our most recent evaluation, to Fortune Diversified
Industries, Inc.'s auditors and the audit committee of Fortune Diversified
Industries, Inc.'s board of directors (or persons performing similar functions):

     a) all significant deficiencies in the design or operation of internal
     controls which could adversely affect Fortune Diversified Industries,
     Inc.'s ability to record, process, summarize and report financial data and
     have identified for Fortune Diversified Industries, Inc.'s auditors any
     material weaknesses in internal controls; and

     b) any fraud, whether or not material, that involves management or other
     employees who have a significant role in Fortune Diversified Industries,
     Inc.'s internal controls; and

6. I have indicated in this quarterly report whether or not there were
significant changes in internal controls or in other factors that could
significantly affect internal controls subsequent to the date of our most recent
evaluation, including any corrective actions with regard to significant
deficiencies and material weaknesses.


11/29/04                    /s/ Carter M. Fortune
Date                       ------------------------------------------
                           Carter M. Fortune, Chief Executive Officer
David W. DELGADO, petitioner, v. PENNSYLVANIA, et al.

No. 16-6009.

Supreme Court of the United States

Nov. 28, 2016.

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.
[Federal Register Volume 66, Number 116 (Friday, June 15, 2001)]
[Notices]
[Page 32654]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-15138]


=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Issuer Delisting; Notice of Application To Withdraw From Listing 
and Registration; (CVB Financial Corporation, Common Stock, No Par 
Value) File No. 1-0394

June 11, 2001.
    CVB Financial Corporation, a California corporation (``Issuer''), 
has filed an application with the Securities and Exchange Commission 
(``Commission''), pursuant to Section 12(d) of the Securities Exchange 
Act of 1934 (``Act'') \1\ and Rule 12d2-2(d) thereunder,\2\ to withdraw 
its Common Stock, no par value (``Security''), from listing and 
registration on the American Stock Exchange (``Amex'' ).
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78l(d).
    \2\ 17 CFR 240.12d2-2(d).
---------------------------------------------------------------------------

    The Issuer stated in its application that it has met the 
requirements of Amex Rule 18 by complying with all applicable laws in 
effect in the state of California, in which it was incorporated, and 
with the Amex's rules governing an issuer's voluntary withdrawal of a 
security from listing and registration.
    The Issuer has also represented that trading in the Security is 
scheduled to begin on the Nasdaq Stock Market and to cease on the Amex, 
at the opening of business on Monday, June 11, 2001. The Issuer's 
application relates solely to the Security's withdrawal from listing on 
the Amex and from registration under Section 12(b) of the Act \3\ and 
shall not affect its obligation to be registered under Section 12(g) of 
the Act.\4\
---------------------------------------------------------------------------

    \3\ 15 U.S.C. 78l(b).
    \4\ 15 U.S.C. 78l(g).
---------------------------------------------------------------------------

    Any interested person may, on or before July 2, 2001 submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW., Washington, DC 20549-0609, facts bearing upon 
whether the application has been made in accordance with the rules of 
the Amex and what terms, if any, should be imposed by the Commission 
for the protection of investors. The Commission, based on the 
information submitted to it, will issue an order granting the 
application after the date mentioned above, unless the Commission 
determines to order a hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.\5\
---------------------------------------------------------------------------

    \5\ 17 CFR 200.30-3(a)(1).
---------------------------------------------------------------------------

Jonathan G. Katz,
Secretary.
[FR Doc. 01-15138 Filed 6-14-01; 8:45 am]
BILLING CODE 8010-01-M
[Federal Register Volume 66, Number 121 (Friday, June 22, 2001)]
[Notices]
[Page 33550]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-15765]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552(b)(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel.
    Date: June 20, 2001.
    Time: 2:30 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NIH, Rockledge 2, Bethesda, MD 20892 (Telephone 
Conference Call).
    Contact Person: Julian L. Azorlosa, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3190, MSC 7848, Bethesda, MD 
20892, (301) 435-1507.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine, 93.306; 93.333, Clinical Research, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: June 18, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-15765 Filed 6-21-01; 8:45 am]
BILLING CODE 4140-01-M
----

            COMMISSION REGULATION (EC) No 1818/2004

of 19 October 2004         

establishing unit values for the determination of the customs value of certain perishable goods

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Regulation (EEC) No 2913/92 of 12 October 1992 establishing the Community Customs Code (1),

Having regard to Commission Regulation (EEC) No 2454/93 of 2 July 1993 laying down provisions for the implementation of Regulation (EEC) No 2913/92 (2), and in particular Article 173(1) thereof,

Whereas:

HAS ADOPTED THIS REGULATION:

Article 1

The unit values provided for in Article 173(1) of Regulation (EEC) No 2454/93 are hereby established as set out in the table in the Annex hereto.

Article 2

This Regulation shall enter into force on 22 October 2004.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 19 October 2004.

For the Commission

Olli REHN            

Member of the Commission

----

(1)OJ L 302, 19.10.1992, p. 1. Regulation as last amended by Regulation (EC) No 2700/2000 (OJ L 311, 12.12.2000, p. 17).

(2)OJ L 253, 11.10.1993, p. 1. Regulation as last amended by Commission Regulation (EC) No 2286/2003 (OJ L 343, 31.12.2003, p. 1).

----

ANNEX

----
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM 1) CONDENSED
CONSOLIDATED BALANCE SHEET AT MARCH 31, 1997; 2) CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS FOR THREE MONTHS ENDED MARCH 31, 1997 AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FORM 10-QSB.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                       1,016,070
<SECURITIES>                                   350,000
<RECEIVABLES>                                  146,037
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             2,221,329
<PP&E>                                       5,279,325
<DEPRECIATION>                               1,084,301
<TOTAL-ASSETS>                              11,504,891
<CURRENT-LIABILITIES>                        2,181,842
<BONDS>                                      1,500,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        16,153
<OTHER-SE>                                   7,197,377
<TOTAL-LIABILITY-AND-EQUITY>                11,504,891
<SALES>                                              0
<TOTAL-REVENUES>                               567,968
<CGS>                                                0
<TOTAL-COSTS>                                1,595,470
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              37,406
<INCOME-PRETAX>                             (1,047,007)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (1,047,007)
<EPS-PRIMARY>                                     (.06)
<EPS-DILUTED>                                        0
        

</TABLE>
ex10-1.htm


Exhibit 10.1

 

Marten Transport, Ltd.

Named Executive Officer Compensation 

 

On May 10, 2016, our Compensation Committee approved an increase to the base salary for each of the company’s named executive officers listed below, retroactive to April 4, 2016. Effective April 4, 2016, the named executive officers will receive the following annual base salaries in the listed positions:

 

	
Name and Position as of May 10, 2016
	 	
Former Base Salary
	 	 	
Base Salary

Effective April 4, 2016
	 
	 	 	 	 	 	 	 	 	 
	
Randolph L. Marten
	 	$	609,960	 	 	$	634,400	 
	
(Chairman and Chief Executive Officer)
	 	 	 	 	 	 	 	 
	
Timothy M. Kohl
	 	$	451,360	 	 	$	469,400	 
	
(President)
	 	 	 	 	 	 	 	 
	
Timothy P. Nash
	 	$	313,560	 	 	$	326,100	 
	
(Executive Vice President of Sales and Marketing)
	 	 	 	 	 	 	 	 
	
James J. Hinnendael
	 	$	253,552	 	 	$	263,700	 
	
(Executive Vice President and Chief Financial Officer)
	 
	
John H. Turner
	 	$	251,784	 	 	$	261,900	 
	
(Senior Vice President of Sales)
Exhibit
32.2





CERTIFICATION
BY CHIEF FINANCIAL OFFICER


PURSUANT
TO 18 U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Annual Report of GenVec, Inc. (the “Registrant”) on Form
10-K as filed with the Securities and Exchange Commission on the date hereof
(the “Report”), I, Douglas J. Swirsky, as Senior Vice President, Chief Financial
Officer, Treasurer and Corporate Secretary of the Registrant, hereby certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:





(1)
            The
      Report fully complies with the requirements of section 13(a) or 15 (d) of
      the Securities Exchange Act of 1934;
and





(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Registrant for the dates and periods covered by the
  Report.





This
certificate is being made for the exclusive purpose of compliance by the Chief
Financial Officer of the Company with the requirements of Section 906 of
the Sarbanes-Oxley Act of 2002, and may not be disclosed, distributed or used by
any person or for any reason other than as specifically required by
law.





A signed
original of this written statement required by Section 906 has been provided to
GenVec, Inc. and will be retained by GenVec, Inc. and furnished to the
Securities and Exchange Commission or its staff upon request.





March
      12, 2010/s/
      Douglas J. SwirskyDouglas
      J. SwirskySr.
      Vice President, Chief Financial Officer,
                Treasurer
      & Corporate Secretary
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                           5,070
<SECURITIES>                                     8,243
<RECEIVABLES>                                    7,866
<ALLOWANCES>                                        37
<INVENTORY>                                     13,020
<CURRENT-ASSETS>                                36,823
<PP&E>                                          25,048
<DEPRECIATION>                                   2,730
<TOTAL-ASSETS>                                  79,355
<CURRENT-LIABILITIES>                           23,298
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           947
<OTHER-SE>                                      52,900
<TOTAL-LIABILITY-AND-EQUITY>                    79,355
<SALES>                                        227,817
<TOTAL-REVENUES>                               234,755
<CGS>                                          197,801
<TOTAL-COSTS>                                  197,801
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 285
<INCOME-PRETAX>                                 19,637
<INCOME-TAX>                                     7,524
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    12,113
<EPS-PRIMARY>                                     1.29
<EPS-DILUTED>                                     1.29
        

</TABLE>
EXHIBIT 10.3







AMENDMENT NUMBER 1


TO EXECUTIVE EMPLOYMENT AGREEMENT







This AMENDMENT is in clarification and amendment of that certain EXECUTIVE EMPLOYMENT AGREEMENT ("Agreement") dated March 28, 2013, (“Effective Date”) by and between T Bancshares, Inc., and its wholly owned subsidiary T Bank, N.A. ("Company"), and D. Craig Barnes ("Executive"), to which this AMENDMENT NUMBER 1 is attached and of which it is hereby made a part.


 


The Agreement is hereby supplemented and amended as follows:


 


1.   Definitions. All terms defined in the Agreement and not otherwise defined herein shall have the same meanings where used herein.


 


2.   Paragraph 3.a. is deleted in its entirety and replaced with the following to be and read: “So long as Executive is employed by the Company in good standing, commencing on May 15, 2015, the Company agrees to compensate the Executive on a salary basis of 5,500.00 semi-monthly.”


 


3.   General.


 


(a) Except as expressly amended and supplemented hereby, the Agreement remains in full force and effect.


 


(b) In the event of any conflict between the terms and conditions of this Amendment and the terms and conditions of the Agreement, the terms and conditions of this Amendment shall prevail.







Executed this 11th day of May, 2015












EXECUTIVE


 


	
            /s/ Shari Jensen                           

	
            /s/ D. Craig Barnes                     


	
WITNESS

	
D. Craig Barnes 


	 	 
	
T BANK N.A. 

	 
	 	 
	 	 
	
            /s/ Shari Jensen                           

	
            /s/ Patrick Howard                      


	
WITNESS

	
President& CEO 


	 	 
	
T BANCSHARES, INC. 

	 
	 	 
	 	 
	
            /s/ Shari Jensen                           

	
            /s/ Patrick Howard                      


	
Witness

	
President & CEO
TOWN OF FARMINGTON, NEW YORK, petitioner, v. Colleen AUSTIN, et vir.

No. 16-365.

Supreme Court of the United States

Oct. 31, 2016.

Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.